Orthopedic Bone Cement Market Size, Trends, Share, Growth, and Opportunity Forecast, 2025 - 2032 Global Industry Analysis By Type (Polymethyl Methacrylate (PMMA), Calcium Phosphate, Glass Polyalkenoate, and Others), By Material (Antibiotic Loaded and Non-antibiotic Loaded), By End-Use (Hospitals, Ambulatory Surgical Centers, and Orthopedic Clinics), By Application (Joint Arthroplasty, Vertebroplasty, Kyphoplasty, and Others), and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Orthopedic Bone Cement Market Report Overview

The Global Orthopedic Bone Cement Market was valued at USD 0.73 Billion in 2024 and is anticipated to reach a value of USD 1.14 Billion by 2032 expanding at a CAGR of 5.8% between 2025 and 2032. The increasing prevalence of orthopedic problems, the aging population, and the growth in joint replacement surgeries are driving market expansion.

To Learn More About This Report, Request A Free Sample Copy

Bone cement plays a key role in modern orthopedics, being extensively employed in joint replacement surgeries such as hip and knee arthroplasties. It provides an effective solution for gluing prosthesis to the bone, promoting speedier recuperation and increased mobility for patients. In recent years, technical breakthroughs have contributed to the creation of high-viscosity bone cements that offer increased mechanical qualities and simplicity of application for surgeons. The orthopedic bone cement market is expanding due to increased occurrences of osteoporosis, arthritis, and the growing senior population, which is particularly sensitive to fractures and joint degradation. The increasing inclination for minimally invasive operations and outpatient orthopedic procedures is also contributing to market expansion as patients and healthcare professionals alike want faster recovery times and fewer hospital stays.

How AI is Transforming Orthopedic Bone Cement Market

AI is transforming the orthopedic bone cement market by speeding surgical procedures and boosting patient outcomes. In the context of joint replacement surgeries, AI-assisted robotic systems are being linked with bone cement application to enhance precision and ensure proper prosthetic implantation. These AI-powered robotic systems assess patient data, provide real-time feedback to surgeons, and optimize cement distribution for greater fixation and fewer problems such as cement leakage. Moreover, AI can detect possible bone cement failures by examining prior surgical data, leading to more tailored and safer treatment strategies.

In manufacturing, AI is utilized to optimize bone cement formulas. By evaluating big datasets on cement compositions, AI can determine the best balance of materials to optimize the material's strength, setting time, and biocompatibility. Additionally, AI-powered technologies in production facilities provide uniformity in the manufacturing process, boosting the quality of bone cement products. AI also plays a crucial role in post-operative monitoring, where advanced algorithms can track patient recovery through wearables, forecast probable issues, and offer early therapies.

Orthopedic Bone Cement Market Major Driving Forces

·         Aging Population and Joint Replacement Demand: The expanding elderly population globally is fuelling demand for joint replacement surgery. Bone cement plays a critical function in anchoring implants during procedures such as hip and knee replacements, further propelling market expansion.

·         Rise in Osteoporosis and Arthritis Cases: The increased incidence of bone-related illnesses including osteoporosis and arthritis, which impact bone density and joint health, is fueling the need for effective surgical remedies that rely on bone cement.

·         Technological Advancements in Orthopedics: Innovations in orthopedic surgery procedures, including minimally invasive approaches and robotic-assisted surgeries, are expanding the employment of high-performance bone cements that offer enhanced fixation and simplicity of application.

·         Growing Healthcare Investments: Increasing healthcare spending, especially in emerging nations, is enhancing access to orthopedic care. This includes the expansion of surgical centers offering joint replacement operations, further bolstering the bone cement market.

Orthopedic Bone Cement Market Key Opportunities

·         Development of Antibiotic-Loaded Bone Cements: There is an increasing demand for bone cements that are pre-loaded with antibiotics to avoid post-surgical infections, especially in high-risk patients having joint replacement procedures. This creates huge market opportunities.

·         Surging Demand in Emerging Economies: Rapid urbanization, improving healthcare infrastructure, and a growing middle-class population in emerging economies such as China and India are creating a fertile ground for market expansion, particularly for bone cement makers.

·         Shift Towards Outpatient Joint Replacement Surgeries: The shift towards outpatient operations for joint replacements is creating opportunities for bone cement materials that offer faster setting periods and increased mechanical qualities to accommodate shorter surgical windows.

·         AI-Powered Surgical Assistance: The integration of AI-powered systems in orthopedic operations presents opportunity for enterprises to work with technology providers to deliver AI-optimized bone cement products that boost surgical precision and patient outcomes.

Orthopedic Bone Cement Market Key Trends

·         Surgeons are increasingly selecting for high-viscosity bone cements due to their improved handling properties, faster setting periods, and higher mechanical strength, which are becoming important for current joint replacement procedures.

·         The use of antibiotic-loaded bone cements to decrease infection risks post-surgery is gaining popularity, particularly in high-infection-risk operations such as knee and hip replacements.

·         The development of biodegradable bone cements is emerging as a key trend, notably for temporary fixation in fracture repair surgeries, as they progressively dissolve without the need for removal.

·         The emergence of 3D-printed, patient-specific prosthetics is driving demand for customized bone cement formulas adapted to particular surgical procedures and implant designs.  

Region-wise Market Insights

North America accounted for the largest market share at 43.6% in 2024 however, Asia Pacific is expected to register the fastest growth, expanding at a CAGR of 6.2% between 2025 and 2032.

To Learn More About This Report, Request A Free Sample Copy

North America dominated the market, driven by the region’s advanced healthcare infrastructure, a high number of joint replacement procedures, and the presence of prominent orthopedic companies. The U.S. is the leading donor, with an expanding elderly population and a strong focus on technical breakthroughs in orthopedic surgery. Companies in North America are also at the forefront of developing new bone cement compositions that minimize surgical time and improve patient outcomes.

·         In March 2025, Smith+Nephew announced that it will showcase its advanced orthopedic reconstruction technologies at the AAOS (American Academy of Orthopaedic Surgeons) 2025 Annual Meeting. The company will feature its latest solutions in joint reconstruction, including innovative approaches in knee, hip, and shoulder procedures. This highlights Smith+Nephew's commitment to enhancing patient outcomes through advanced surgical techniques and cutting-edge technology.

The Asia Pacific area is predicted to exhibit the greatest development, with a CAGR of 6.2% throughout the forecast period. Countries such as China and India are witnessing higher healthcare spending and rising awareness regarding joint health, which is contributing to market growth. The increased demand for economical healthcare solutions and the rise in joint-related disorders are pushing the usage of orthopedic bone cement in the region.

In Europe, the industry is focusing on developing antibiotic-infused bone cements to lower post-surgical infection risks, especially in older patients. Countries such as Germany and the UK are leading this trend due to their elderly populations and modern healthcare systems.

Recent Developments

·         In March 2025, Zimmer Biomet launched TEKCEM 1G and TEKCEM 3G antibiotic bone cements in India, designed to treat bone infections and promote effective surgical outcomes. These cements offer high local antibiotic concentrations at the surgical site, reducing infection risks in procedures such as joint replacements. TEKCEM’s introduction aims to meet the rising demand for orthopedic solutions in India’s healthcare market.

·         In November 2024, Zimmer Biomet has announced FDA 510(k) clearance for the Rosa Partial Knee System, which is designed to assist surgeons in performing partial knee arthroplasty (PKA) with enhanced precision and data-driven insights. The system integrates Zimmer Biomet’s existing Knee Robotics platform and uses real-time intraoperative data to optimize patient outcomes. This is expected to expand the use of robotic technology in knee procedures.

·         In August 2024, Heraeus Medical USA has launched its Copal® GV, a dual antibiotic-loaded bone cement. This product contains both gentamicin and vancomycin and is specifically designed for use in orthopedic procedures requiring infection control. The combination of antibiotics is intended to prevent and treat infections in joint replacement surgeries.

Market Competition Landscape

The orthopedic bone cement industry is highly competitive, with key competitors consistently innovating to acquire a greater market share. Leading firms are working on creating antibiotic-infused and high-viscosity bone cement formulations that suit the growing demands of surgeons and patients. The major market players are also extending their presence in new regions, particularly in the Asia Pacific region, to tap into the growing demand for orthopedic operations. Key initiatives include mergers, acquisitions, and partnerships with healthcare providers to extend product portfolios and improve geographic reach.

Key players in the global orthopedic bone cement market implement various organic and inorganic strategies to strengthen and improve their market positioning. Prominent players in the market include:

·         Stryker Corporation

·         Zimmer Biomet Holdings, Inc.

·         DePuy Synthes (Johnson & Johnson)

·         Heraeus Holding GmbH

·         Smith & Nephew Plc

·         Exactech, Inc.

·         DJO Global, Inc.

·         Medtronic Plc

·         T. A. G. Medical Products Corporation Ltd.

·         Teknimed

·         G-21 S.r.l.

·         Cardinal Health

·         Orthofix Medical Inc.

·         Osteogenics